Themis Medicare Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 8th May, 2023, intimating you about the earning conference call for Q4 & FY23 with Analysts/Investors held on 15th May, 2023, please find attached herewith the transcript of the aforesaid conference call. The above information is also available on the website of the Company at https://www.themismedicare.com

pdf

Themis Medicare Ltd.

15 May 2023

134.65

0.22%

Earnings Call

THEMIS MEDICARE LTD. - 530199 - Audio Recording Of The Earnings Conference Call For Q4 & …

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on May 15th, 2023 for the quarter and year ended March 31, 2023, has been uploaded on the website of the Company at https://www.themismedicare.com/uploads/statutory/pdf/TML-Q4-&-FY23-Earnings-Call-Audio-dated-15.05.2023.mp3 Kindly take the aforesaid on records.

pdf

Themis Medicare Ltd.

17 Feb 2023

134.65

0.22%

Earnings Call

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company did a one on one physical meeting with Analysts/Investors on Thursday, 16th February 2023; the details of the same are given below: Sr. no. Name Venue 1 Nuvama Wealth Management Themis Office Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.

pdf

Themis Medicare Ltd.

13 Feb 2023

134.65

0.22%

Earnings Call

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 7th February, 2023, intimating you about the earning conference call for Q3 & 9M FY23 with Analysts/Investors held on 10th February, 2023, please find attached herewith the transcript of the aforesaid conference call. The above information is also available on the website of the Company at https://www.themismedicare.com

pdf

Themis Medicare Ltd.

10 Feb 2023

134.65

0.22%

Earnings Call

THEMIS MEDICARE LTD. - 530199 - Audio Recording Of The Earnings Conference Call For Q3 & …

BSE India

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on February 10th 2023 for the quarter ended December 31, 2022, has been uploaded on the website of the Company at https://www.themismedicare.com/investor-relations/earningcallstranscripts Kindly take the aforesaid on records.

pdf

Themis Medicare Ltd.

19 Dec 2022

134.65

0.22%

Earnings Call

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

In reference to intimation dated 16th December, 2022, we wish to inform you that the meeting stands cancelled for today. Further, the exchange will be informed about the rescheduling of the same as and when decided. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.

pdf

Themis Medicare Ltd.

01 Dec 2022

134.65

0.22%

Earnings Call

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company did physical meetings with Analysts/Investors on Thursday, 1st December 2022; the details of the same are given below: Sr. no. Name Venue 1 Counter Cyclical PMS Mumbai 2 Enam Holdings Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com

pdf

Themis Medicare Ltd. Conference Calls and Earnings Call Transcripts